Company: INSP
Filing Date: 2025-11-03
Form Type: 10-Q
Source: 0001609550-25-000053
Chunk: 90

Company: Inspire Medical Systems, Inc.
Filing Date: 2025-11-03
Form: 10-Q
Item: Part I, Item 8
Chunk 90
---
5 million and $28.2 million, respectively, and for the nine-month periods ended September 30, 2025 and 2024, stock-based compensation expense was $102.2 million and $86.9 million, respectively, and is included within the segment expense captions of cost of goods sold, research and development expense, and SG&A expense. Revenue by geographic region is as follows: Three Months EndedNine Months EndedSeptember 30,September 30,2025202420252024United States$214,394 $195,828 $615,150 $539,407 All other countries10,107 7,363 27,754 23,679 Total revenue$224,501 $203,191 $642,904 $563,086 Long-lived tangible assets by geographic location were as follows:September 30, 2025December 31, 2024United States$90,661 $71,008 All other countries845 917 Total long-lived tangible assets$91,506 $71,925 

9. Income Per Share

Basic net income per share is computed by dividing the net income by the weighted average number of shares of common stock outstanding during the period. Diluted net income per share is computed by dividing the net income by the weighted average number of shares of common stock and dilutive potential shares of common stock outstanding during the period. The components of net income per share are as follows:

26

Table of ContentsINSPIRE MEDICAL SYSTEMS, INC. NOTES TO CONDENSED FINANCIAL STATEMENTS (Unaudited) (Table amounts in thousands, except share and per share amounts)

Three Months EndedNine Months EndedSeptember 30,September 30,2025202420252024Numerator:Net income$9,932 $18,497 $9,332 $18,285 Denominator:Weighted average number of common shares outstanding — basic29,332,376 29,879,621 29,512,495 29,741,720 Dilutive effect of stock options248,368 536,641 349,384 624,931 Dilutive effect of restricted stock units8,067 61,608 69,071 66,600 Dilutive effect of performance stock units11,412 141,734 3,804 128,416 Dilutive effect of shares issuable